• Keine Ergebnisse gefunden

Emery-Dreifuss Muscular Dystrophy

N/A
N/A
Protected

Academic year: 2022

Aktie "Emery-Dreifuss Muscular Dystrophy"

Copied!
7
0
0

Wird geladen.... (Jetzt Volltext ansehen)

Volltext

(1)

orphan a nesthesia

Anaesthesia recommendations for patients suffering from

Emery-Dreifuss Muscular Dystrophy

Disease name: Emery-Dreifuss Muscular Dystrophy (EDMD) ICD 10: G71.0

Synonyms: Benign Scapuloperoneal Muscular Dystrophy, Hauptmann-Thannhauser Muscular Dystrophy, EDMD 1 (X-linked affecting EMD gene), EDMD 2/3 (autosomal dominant/recessive affecting LMNA gene)

Other laminopathies may be phenotypically similar.

Medicine in progress Perhaps new knowledge Every patient is unique Perhaps the diagnostic is wrong

orphan a nesthesia

Anaesthesia recommendations for patients suffering from

3-M syndrome

Disease name: 3-M syndrome ICD 10: Q87.1

Synonyms: Dolichospondylic dysplasia, 3Μ dwarfism, gloomy face syndrome, Le Merrer syndrome

3-M syndrome is a recessive autosomal genetic growth disorder, characterized by significant pre- and postnatal growth retardation. It is listed as a rare or an “orphan” disease having a prevalence in Europe of less than 1 person per 2000 in the general population or affecting less than 200000 people in the US population, with fewer than 100 patients having been reported in the medical literature since 1975.

The name of the disease originates from the initials of the three authors, Miller, McKusick and Malvaux, who first reported the syndrome in the literature. The disease is caused by mutations in Cullin 7 (CUL7) gene on chromosome 6p21.1, in most cases, or in the Obscurin-like 1 (OBSL1) gene on chromosome 2q35-36.1 encoding a cytoskeletal adaptor protein. A third gene has recently been identified, encoding the Coiled coil domain containing protein 8 (CCDC8), on chromosome 19q13.32.

Medicine in progress Perhaps new knowledge Every patient is unique

Perhaps the diagnostic is wrong

(2)

Disease summary

Joint contractures (Achilles tendons, elbows and spine). Posterior neck and lower back involvement may result in a rigid spine.

Humeroperoneal muscle weakness by adolescence, later involving the proximal limb girdles.

Cardiac conduction abnormalities (PR prolongation & complete heart block), atrial and ventricular arrhythmias and dilated cardiomyopathy usually beginning in the 2nd– 3rddecade of life.

Typical surgery x Tendon release

x Corrective spinal surgery x Caesarean Section

x Permanent pacemaker / defibrillator insertion

Type of anaesthesia

All forms of anaesthesia are possible. Intubation and central neuro-axial blocks may be difficult due to joint contractures.

Although evidence is lacking it may be prudent to avoid suxamethonium and inhalational anaesthetics during the first decade of life to avoid anaesthesia-induced rhabdomyolysis.

Necessary additional diagnostic procedures (preoperative) Electrocardiogram (ECG).

Echocardiography and 24 hour ambulatory ECG telemetry are recommended.

Cardiac electrophysiological testing should be considered in patients with conduction defects.

(3)

Particular preparation for airway management

There is the potential for reduced gut motility, aspiration risk should be assessed and managed. The airway plan should include options for dealing with a difficult airway secondary to restricted neck movement.

Particular preparation for transfusion or administration of blood products May be at increased risk of intra-operative bleeding; mechanism not fully understood.

Consider anti-fibrinolytics and early treatment of acquired coagulopathy.

Particular preparation for anticoagulation Not reported.

Particular precautions for positioning, transport or mobilisation Take care when positioning contractures.

Probable interaction between anaesthetic agents and patient’s long term medication Not reported.

Anaesthesiologic procedure

An opioid sparing technique and careful titration of muscle relaxants will limit the impact on post-operative respiratory function.

(4)

Particular or additional monitoring

Invasive arterial pressure monitoring is prudent. Central venous pressure monitoring may be of benefit.

Neuromuscular blockade should be monitored routinely.

Possible complications Decompensation of existing cardiac abnormalities:

x Conduction defects, including complete heart block and atrial standstill x Cardiac failure

x Ventricular and supraventricular arrhythmias.

Prolonged neuromuscular blockade.

Postoperative care

Patients are at risk of respiratory compromise. High dependency care should be considered particularly following intra-abdominal or thoracic surgery.

Information about emergency-like situations / Differential diagnostics

caused by the illness to give a tool to distinguish between a side effect of the anaesthetic procedure and a manifestation of the disease

Anaesthesia induced rhabdomyolysis may present as a Malignant Hyperthermia type picture.

Hyperkalaemia and life-threatening arrhythmias are possible.

Ambulatory anaesthesia

Joint contractures and muscle weakness may affect gait and stability.

(5)

Obstetrical anaesthesia Require early investigation to inform decision making.

Elective Caesarean Section may be necessary, and the feasibility and impact of central neuro-axial blocks need to be assessed.

(6)

Literature and internet links

1. Emery A. The Muscular Dystrophies. Lancet. 2002;359:687-95

2. Meune C, Van Berlo JH, Anselme F et al. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med. 2006;354:209-10

3. Morrison P, Jago R. Emery-Dreifuss Muscular Dystrophy. Anaesthesia. 1991;46:33-35 4. Pasotti M, Klersy C, Pilotto A et al. Long-term Outcome and Risk Stratification in Dilated

Cardiolaminopathies. J Am Coll Cardiol. 2008;52:1250-1260

5. Jensen V. The anaesthetic management of a patient with Emery-Dreifuss muscular dystrophy.

Can J Anaesth. 1996;43:968-71

6. Aldwinckle R, Carr A. The anaesthetic management of a patient with Emery-Dreifuss muscular dystrophy for orthopaedic surgery. Canadian Journal of Anaesthesia. 2002;49:467-470 7. Lerman J. Perioperative management of the paediatric patient with coexisting neuromuscular

disease. Br J Anaesth. 2011;107(S1):i79-i89

8. Hermans M, Pinto Y, Merkies I, de Die-Smulders C, Crijns H, Faber C. Hereditary muscular dystrophies and the heart. Neuromuscul Disord. 2010;20:479-492

9. Nigro G, Russo V, Ventriglia V et al. Early onset of cardiomyopathy and primary prevention of sudden death in X-linked Emery-Dreifuss muscular dystrophy. Neuromuscul Disord. 2010;

20:174-177

10. Berlo J, de Voogt W, van der Kooi A et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med. 2005; 83:79-83

11. Kim O, Elliott D. Elective caesarean section for a woman with Emery-Dreifuss muscular dystrophy. Anaesth Intensive Care. 2010; 38:744-7

12. Shende D, Agarwal R. Anaesthetic Management of a Patient with Emery-Dreifuss Muscular Dystrophy. Anaesth Intensive Care. 2002;30:372-375

13. Choudhry D, Mackenzie W. Anesthetic Issues with a Hyperextended Cervical Spine in a Child with Emery-Dreifuss Syndrome. Anesth Analg. 2006;103:1611-1613

14. Funnell A, Morgan J, McFadzean W. Anaesthesia and orphan disease: management of cardiac and perioperative risks in a patient with Emery–Dreifuss muscular dystrophy. Eur J Anaesthsiol. 2012; 29:596-598

15. Schuster F, Wessig C, Schimmer C et al. In Vitro Contracture Test Results and Anaesthetic Management of a Patient with Emery-Dreifuss Muscular Dystrophy for Cardiac

Transplantation. Case reports in anaesthesiology. 2012.

http://dx.doi.org/10.1155/2012/349046

(7)

Last date of modification: January 2014

These guidelines have been prepared by:

Author

Anthony Funnell, Anaesthesiologist, Morriston Hospital, Heol Maes Eglwys, Swansea, United Kingdom

anthony.funnell@gmail.com Peer revision 1

Frank Schuster, Anaesthesiologist, University Hospital Wuerzburg, Germany schuster_f@klinik.uni-wuerzburg.de

Peer revision 2

Karim Whabi, Cardiologist, Université Paris-Descartes, Hôpital Cochin, Paris, France denis.duboc@cch.aphp.fr

Rabah Ben Yaou, Neurologist, Université Pierre et Marie Curie-Paris 6, UM 76, CNRS, UMR7215, Service des Essais Cliniques et des Bases de Données , Paris, France

r.benyaou@institut-myologie.org

Referenzen

ÄHNLICHE DOKUMENTE

(b) Representative steady-state Ca 2+ transient amplitudes at 0.5 Hz stimulation. 4.14.3 Influence of mechanical stress on Ca 2+ homeostasis skeletal muscle fibers To determine

To understand the role of miRNAs in DGC signaling and their contribution to MDs, in particular during stress, we screened several miRNAs that are predicted to

We have recently demonstrated that the fukutin-related protein gene ( FKRP ) is mutated in a severe form of CMD (MDC1C), characterized by the inability to walk, leg muscle

The aim of the present work is to investigate patient-reported outcomes, such as the health-related quality of life (HRQOL) and psychosocial adjustment in patients with

We show that the material- and time-saving method using reverse protein arrays can successfully be employed for the quantitative and reproducible measurement of muscle proteins

Since gene therapeutic approaches in the treatment of muscular dystrophy still present a variety of problems, an alternative and safe approach to achieve expression of a

Dynamics and regulation of the actin cytoskeleton in the motoneuron disease Spinal Muscular Atrophy

Interestingly, we could previously show outgrowth defects in sympathetic-like PC12 cells with SMN knock-down, while a SMA model of the motoneuron-like NSC34 cell line